Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|3|3|305-320

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.3, 2003-01, pp. : 305-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting DNA Topoisomerase I with Non-Camptothecin Poisons

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1238-1257

Bentham Science Publishers

Access to resources Recommend Favorite

New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4389-4409

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes

By  

Current Drug Targets, Vol. 17, Iss. 16, 2016-12 ,pp. : 1928-1939

Bentham Science Publishers

Access to resources Recommend Favorite

Non-camptothecin topoisomerase I active compounds as potential anticancer agents

By Long B.H.   Balasubramanian B.N.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 635-666

Informa Healthcare

Access to resources Recommend Favorite

Dual Topoisomerase I / II Inhibitors in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 339-353

Bentham Science Publishers

Access to resources Recommend Favorite